clepp (@cl2pp) 's Twitter Profile
clepp

@cl2pp

Leveraging entropy a post at a time. Co-Founder & CPO @bioprotocol

ID: 1031993664573198336

linkhttp://bio.xyz calendar_today21-08-2018 19:57:17

801 Tweet

803 Takipçi

1,1K Takip Edilen

DeSci.Berlin (@desciberlin) 's Twitter Profile Photo

Thank you to everyone who made the 4th edition of DeSci.Berlin so special. The speakers, panelists, workshop hosts, sponsors, and everyone who joined, virtually or in person; your energy, curiosity, and commitment to this growing ecosystem made it unforgettable!

Thank you to everyone who made the 4th edition of <a href="/DeSciBerlin/">DeSci.Berlin</a> so special.

The speakers, panelists, workshop hosts, sponsors, and everyone who joined, virtually or in person; your energy, curiosity, and commitment to this growing ecosystem made it unforgettable!
clepp (@cl2pp) 's Twitter Profile Photo

It was an absolute pleasure hosting the panel "Bringing Science on-chain" at DeSci Berlin. Thank you to the panelists for taking the time out of your busy lives to tell us about if and how decentralized infrastructures can help accelerate scientific inquiry.

Long COVID Labs (@longcovidlabs) 's Twitter Profile Photo

We’re investigating possible biomarkers for SARS-CoV- 2 viral persistence! ✨ Here’s our founder Rohan Dixit having his blood drawn by a mobile phlebotomist, as we run our biomarkers through a trial run. 🩸 A definitive biomarker to show whether or not the SARS-CoV-2 virus is still

seanwbren.eth (@seanwbren) 's Twitter Profile Photo

Explore ideas like this with the Aubrai agent, add it to the Bio Protocol knowledge graph, and then immediately pay to the new compound via Coinbase Developer Platform🛡️ x402 to Pump Science That's what scientific agents are about.

Bio Protocol (@bioprotocol) 's Twitter Profile Photo

“9 gov grants rejected. Most places turned me down. Only dumb luck got us funded.” At #DeSciBerlin, Ed Boyden posed a bold question to every scientist, founder and builder in the room: Can we engineer serendipity? This talk was something else 🧵👇

Bio Protocol (@bioprotocol) 's Twitter Profile Photo

Congrats to Cerebrum DAO 🧠 on progressing towards their first decentralized clinical trial ⚡️ From DeSci funding → human trials in months, rather than years. Accelerate brain health. Track the team's progress in Molecule Labs 👇

Congrats to <a href="/Cerebrum_DAO/">Cerebrum DAO 🧠</a> on progressing towards their first decentralized clinical trial ⚡️

From DeSci funding → human trials in months, rather than years.

Accelerate brain health.

Track the team's progress in <a href="/Molecule_dao/">Molecule</a> Labs 👇
clepp (@cl2pp) 's Twitter Profile Photo

It was a pleasure reviewing the history of fundraises and launchpads in crypto and what DeSci can learn from it. I am very excited about the recent models that many of the new launchpads are experimenting with. We at Bio Protocol pay close attention and are working hard to

Long COVID Labs (@longcovidlabs) 's Twitter Profile Photo

✨ July 2025 Updates from the Lab:✨ Today, we're announcing two major updates as part of our ongoing mission to accelerate a cure for Long COVID. TLDR: ✅ Patient Grant Fund: We’re creating a Patient Grant Fund to help patients access Long COVID treatments. We’ll be

✨ July 2025 Updates from the Lab:✨ 

Today, we're announcing two major updates as part of our ongoing mission to accelerate a cure for Long COVID.  

TLDR:  

✅ Patient Grant Fund:  We’re creating a Patient Grant Fund to help patients access Long COVID treatments.  We’ll be
clepp (@cl2pp) 's Twitter Profile Photo

More and more such cases will surface. As accessibility for intelligence becomes ubiquitous, individual health outcomes will dramatically improve.

Bio Protocol (@bioprotocol) 's Twitter Profile Photo

Highlights from last week in the Bio ecosystem: 🧪 veBIO staking contract 👾 BioAgent plugins connect to knowledge sources 🔮 Bio points preview 🔬 Decentralized fertility trials 💛 Potential $1B+ longevity deal Read the full progress update:

clepp (@cl2pp) 's Twitter Profile Photo

AIs and tooling around AI systems are evolving faster than anything previously seen, while the impact these technologies are already having today is astounding. And what people tend to forget: This is the worst the technology is ever going to be. It will only get better from

clepp (@cl2pp) 's Twitter Profile Photo

Some thoughts on Bio Protocol's launchpad and where we're heading. 𝐁𝐢𝐨'𝐬 𝐡𝐢𝐬𝐭𝐨𝐫𝐢𝐜𝐚𝐥 𝐟𝐨𝐜𝐮𝐬 𝐨𝐧 𝐥𝐚𝐫𝐠𝐞𝐫 𝐟𝐮𝐧𝐝𝐫𝐚𝐢𝐬𝐞𝐬 We've leaned into larger fundraises at Bio to give teams the runway for ambitious science right out of the gate. E.g. Think bioDAOs

Some thoughts on Bio Protocol's launchpad and where we're heading.

𝐁𝐢𝐨'𝐬 𝐡𝐢𝐬𝐭𝐨𝐫𝐢𝐜𝐚𝐥 𝐟𝐨𝐜𝐮𝐬 𝐨𝐧 𝐥𝐚𝐫𝐠𝐞𝐫 𝐟𝐮𝐧𝐝𝐫𝐚𝐢𝐬𝐞𝐬
We've leaned into larger fundraises at Bio to give teams the runway for ambitious science right out of the gate. E.g. Think bioDAOs
clepp (@cl2pp) 's Twitter Profile Photo

Most experiments don’t get repeated. It's not that they're difficult to duplicate; the inconvenience lies in the tools themselves. You get a PDF, a vague method section, maybe a spreadsheet if you’re lucky. The absence of a unified operational framework means that verifying

Shriya Bhat (@shriyapbhat) 's Twitter Profile Photo

1 in 10 Americans will be affected by a rare disease. But very few will get a drug. Even with current incentives for solving rare, most are still too small to fund. I spoke with YC biotech founder Ethan Perlstein bio/acc about how crypto might be a new vehicle for funding rare. 🧵

1 in 10 Americans will be affected by a rare disease. 
But very few will get a drug.

Even with current incentives for solving rare, most are still too small to fund.

I spoke with YC biotech founder <a href="/eperlste/">Ethan Perlstein bio/acc</a> about how crypto might be a new vehicle for funding rare. 🧵